Should we allow private markets for human organs?

Richard Epstein • APRIL 19, 2016

Richard Epstein of New York University School of Law argues in favor of private markets for human organs. According to Epstein, the best way to make progress in society on practically any issue is to harness the gains from trade. In the United States, however, laws prohibit markets in organ, and the predictable result is stagnation. Epstein holds that by monetizing the situation on both sides of the transaction, we can save more lives at virtually no cost. He argues that only by committing to long-term deregulation in this area, not through short-term piloting or experimentation, will we enable true solutions to emerge.

This video is from the MacLean Center for Clinical Medical Ethics at the University of Chicago. Visit the original source.
If the video on this page is broken, please report it.
This page has been viewed 942 times.

"I needed to know who the thought leaders were on a particular policy issue. A quick search through HealthPolicy.tv saved me hours!"

— Chris K., Palo Alto, CA